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Product ion spectra of fifteen monoglutathione and diglutathione conjugates have been 
measured using activation by 6000-eV collisions with helium in the third field-free region of 
a four-sector tandem mass spectrometer of EBEB configuration. Fragmentation patterns in 
the cation spectra have been analyzed for decompositions of the glutathione moiety that 
would permit recognition of an unknown as a glutathione conjugate. Five spectra from an 
earlier study of high-energy collisional activation on a BEEB four-sector instrument have also 
been included in this analysis. A suite of appropriate ions was found to occur consistently, 
including ions of m/z 307 comprising the glutathione tripeptide and the complementary ion 
[MH - 3071+ or the ion radical [MH - 3041+‘. (I Am Sot Mass Spectrum 1992, 3, 815-822) 
T he chemical reactions of glutathione, including those enzymatically catalyzed, are important components of the defense system of every cell 
against xenobiotic insult. Conjugation with glutathione 
can also inactivate therapeutic agents, and is involved 
in regulation of endogenous substrates. 
Mass spectral analysis of this important and widely 
encountered family of metabolites was not satisfacto- 
rily achieved before the advent of desorption tech- 
niques. Some successful applications have been re- 
ported using field desorption (FD); however, derivati- 
zation appears to provide more reliable FD results [ 11. 
Subsequently fast atom bombardment (FAB) [2], 
plasma desorption [31, and electron ionization follow- 
ing laser ablation [4] have been successfully used in 
this and other laboratories to analyze intact glu- 
tathione conjugates. In cation spectra, abundant proto- 
nated and/or natriated molecular ions are usually 
observed, along with class-characteristic ions of m/z 
306,307, or 308, corresponding to glutathione, molecu- 
lar weight 307 Da. 
Tandem mass spectrometry has also been evaluated 
for the dual purposes of working with incompletely 
purified metabolites and of inducing more extensive 
fragmentation by collisional activation. This work has 
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mainly been carried out with FAB, although FD was 
used in one early report [5]. Spectra from more than a 
dozen glutathione conjugates activated by low-energy 
collisions have been published [6-111 and another 
dozen have been analyzed by high-energy collisional 
activation [ 12-191. Derivatized glutathione adducts 
have also been characterized by collisionally induced 
dissociation (CID) [ll, 20-241. 
Fragmentation is indeed found to be enhanced by 
collisional activation, and, in general, fragmentation 
patterns produced by high- and low-energy collisions 
have more in common than not. However, the recogni- 
tion of class-characteristic ions in either low- or high- 
energy CID experiments has been uncertain. This has 
led laboratories using quadrupole-based tandem in- 
struments to evaluate detection of constant neutral 
losses as an alternative strategy for recognizing glu- 
tathione conjugates. Straub [61 proposed that this class 
could be recognized by the neutral loss of 275 Da 
under collisional activation at 29 eV. Heeremans et al. 
[7] reported the loss of 146 Da using 45-eV collisions. 
Haroldson et al. [Sl, analyzing low-energy collisions of 
seven different conjugates, observed both of these 
losses, as well as loss of 129 Da. None of these losses 
was observed consistently in all seven spectra, al- 
though [M + H - 2321+ ions were detected in the 
product ion scans of all seven samples, formed by 
multistep processes. This latter group has favored the 
strategy of constant neutral loss scanning for 129 Da 
[lo]. It should be noted that these four dissociations, 
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like most induced by low-energy collisions, involve 
formation of even-electron or closed-shell products. 
High-energy collisions have also been used to acti- 
vate glutathionc conjugate ions. Lay et al. [ 131 reported 
the elimination of neutral fragments of 75 and 129 Da 
from three protonated conjugates activated by colli- 
sions with helium at 8000 eV in a three-sector instru- 
ment. A series of cation spectra have been reported, 
measured on the BEEB four-sector instrument at the 
National Institute of Environmental Health Sciences 
[14~16], which record losses of neutral fragments of 
masses 75 and 129, and also formation of ions of mass 
306 or 307. Deterding and co-workers [16] have 
analyzed both cation and anion spectra of glutathi- 
one conjugates measured on that instrument. Even- 
electron ions of m/z 306 or the ion radical, m/z 
307, were observed in fragmentation of all five of the 
protonated conjugates studied. [ MH ~ 129]+ ions were 
present in four spectra. Formation of [MH - 75]+ ions, 
of [MH - 232]+ ions, and of ion radicals of m/z 130 
were each detected in three cases. Ion radicals are 
commonly generated in high-energy collisional activa- 
tion from protonated (even-electron) molecules. 
The variations observed in the fragmentation pat- 
terns in this combined body of literature are assumed 
to reflect the chemical natures of the conjugation part- 
ners of glutathione, and also the differences in frag- 
mentation processes induced by high- and low-energy 
collisions. In the present study we summarize high- 
energy CID studies on 15 additional protonated glu- 
tathlone conjugates and integrate our results with the 
Deterding study [16] to assess general patterns of frag- 
mentation in high-energy CID. 
Experimental 
Mass Spectromety. Measurements were obtained on a 
JEOL (Tokyo, Japan) HXllO/HXllO four-sector mass 
spectrometer (EBEB, where E represents an electric 
sector and B a magnetic sector). Conventional mag- 
netic scans were obtained with the first two sectors 
(EB), using a JEOL FAB gun and a JEOL DA5000 data 
system. The FAB gun was operated at 6 kV with 
xenon. The resolution was 3000. 
Tandem measurements were obtained by utilizing 
all four sectors (EBEB) on the JEOL HXllO/HXllO 
instrument. Product ions were analyzed with MS-II, 
following mass selection of the precursor ions by MS-l 
and collisional activation. The resolution in both MS-I 
and MS-II was 1000. Helium was used for CID in the 
third field-free region, at pressures sufficient to attenu- 
ate the precursor ion by 80%. The accelerating voltage 
in, MS-I was 10 kV, and the collision cell was floated to 
4 kV. Spectra were plotted with the most abundant 
fragment ion at or near 100% relative abundance. 
Samples (l-10 ng) were dissolved in methanol 
(Fisher Scientific Co., Fair Lawn, NJ) or a suitable 
methanol/water mixture and added to a matrix on the 
probe tip. The matrix was either monothioglycerol 
(Sigma Chemical Co., St. Louis, MO) or 3-nitrobenzyl 
alcohol (Aldrich Chemical Co., Milwaukee, WI). 
Glutathione Conjugates. The structures of the ten 
monoconjugates and five diconjugates studied are 
shown in Figure 3. Conjugates of phenylglyoxal dithio- 
hemiacetal (II and XIV), dithiomandelic acid (Ill) and 
lactoic acid (VII) were synthesized in the laboratory of 
Dr. Donald Creighton [24, 251. The glutathione conju- 
gate of epoxy-dimethylbilirubin (VIII) was isolated in 
the laboratory of Dr. G. Odell, University of Wisconsin 
at Madison [18, 191. The monoconjugate of cyclophos- 
phamide (I) and the diconjugate of phosphoramide 
mustard (XI) were synthesized by Z. Yuan [4, 171. 
Conjugates of 2,4-nitrobenzene (VI) and styrene oxide 
(V) were synthesized chemically [2] by X. Yu in this 
laboratory. Monoglutathione and diglutathione conju- 
gates IX, XII, and XIII were formed by chemical reac- 
tion of glutathione with diaziquone (2,5-diaziridinyl- 
3,6-bis(carboethoxyamino)-1,4-benzoquinone) (AZQ) 
[26]. Mixed disulfide conjugates of [Argsl-vasopressin 
(X, XV) were synthesized chemically in this laboratory 
[27]. Hexyl glutathione (IV) was purchased from Sigma 
Chemical Co. 
Results 
Initially, FAB spectra were obtained for the 15 glu- 
tathione conjugates. Protonated molecular ions were 
observed for all the compounds. These [M + HI+ ions 
were subsequently fragmented via high-energy colli- 
sions with helium. The results of the CID experiments 
are summarized in Table 1. To facilitate the discussion 
of glutathlone fragmentation, the convention proposed 
by Gaskell and co-workers [8] has been adapted as 
summarized in Scheme I. Neither the ionizing proton 
nor proton transfers are shown. 
The ten monoglutathione conjugates studied en- 
compass a variety of chemical structures (Figure 1). 
Figure 2 presents the CID spectrum of the protonated 
monoglutathione conjugate of cyclophosphamide (I) as 
a representative spectrum. Only ions containing 35C1 
and l*C were selected by MS-I for activation in this 
case. There are a number of glutathione-related frag- 
ments recorded: a, b, d, e, f, g, i, k, and R, as listed in 
Table 1. Additionally, several fragment ions are de- 
rived from the drug moiety, including the most abun- 
dant, m/z 211[17]. It should be noted that ions of m/z 
307 (type i) comprise the glutathione moiety and are 
ion radicals. 
The CID spectrum of compound IX, derived from 
the antitumor drug AZQ, is shown in Figure 3. As 
usual, ions containing only 12C were selected by MS-I, 
and thus r3C isotopic peaks are absent, for example, 
around the peak at m/z 562. All of the glutathione 
ions shown in Scheme I are formed (Table 1) except the 
multistep loss of 232 Da (g). Abundant ions of masses 
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Figure 1. Structures of glutathione conjugates used in this skdy. The structure for glutathione, 
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416, 417, and 418 are formed by loss of 275, 274, and 
273 Da. These are interpreted to be even-electron ions 
and ion radicals of the general class d, formed by 
cleavage of a C-S bond, with and without hydrogen 
transfers. A similar multiplicity of processes is re- 
flected in formation of ions of m/z 384, 385, and 386 
by cleavage of the other C-S bond. Major peaks at m/z 
618 and 312 correspond to ions formed by loss of the 
ethylcarboxyl side chain in the drug moiety. 
A spectrum of the mixture of isomeric glutathione 
conjugates formed from styrene oxide was chosen for 
presentation in Figure 4, because it has been studied 
by other laboratories as well [16], and because it is 
readily available as a standard. All ions summarized 
in Scheme I and Table 1 are present in medium to high 
abundance. Notably, the base peak in the spectrum 
corresponds to the ion radical of glutathione at m/z 
307. 
CID spectra of five diglutathione conjugates are also 
summarized in Table 1. It should be noted that glu- 
tathione is conjugated through both thioether and 
disulfide bonds in this set of samples. In all cases three 
or more ions from the class-characteristic suite are 
present, in particular, glutathione ions of m/z 307 or 
308. In the CID spectrum (shown in Figure 5) of the 
diconjugate derived from phenylglyoxal dithiohemiac- 
eta1 (XIV), ions of m/z 307, in concert with a suite of 
other class-characteristic ions (Table 11, reveal the pres- 
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Figure 3. CID spectrum of IX, a monoglutathione conjugate 
derived from AZQ, [MHl+ = 458 Da. 
ence of one glutathione moiety. The presence of a 
second is not obvious from the spectrum, apart from 
the mass-to-charge ratio of the molecular ion. The most 
abundant fragment ions have m/z 339 and are as- 
signed as GSSH+ [27]. The presence of two glutathione 
units is clearly revealed only in the CID spectrum of 
diglutathione conjugate XV, where sequential losses 
produce intense peaks at m/z 1390 (MH - 307) and 
m/z 1085 (MH - 6121 (Table 1). 
Table 1 indicates that, with the exception of conju- 
gate VIII, spectra of the monoglutathione and diglu- 
tathione conjugates studied here under high-energy 
collisional activation exhibit peaks of medium to high 
intensity at m/z 307 or 308. These peaks correspond to 
the glutathione moiety and would assist class recogni- 
tion in an unknown spectrum. In the low-mass range, 
most of these spectra contain medium intensity peaks 
corresponding to ions b of m/z 76 comprising glycine 
from glutathione, and to ions f of m/z 130 comprising 
the glutamyl residue. The complementary processes, 
loss of 75 (ion a> and loss of 129 (ion e> are frequently, 
though not always, detected in good abundance (Table 
1). 
Cleavages of bonds on either side of sulfur were 
reported more than 25 years ago to be characteristic of 
thioethers [28]. This bond cleavage was found to be 
accompanied occasionally by hydrogen transfers; how- 
ever, the structural requirements for hydrogen transfer 
have remained elusive. This same situation is observed 
in the thioether spectra summarized in Table 1. The i 
ions formed by scission of a bond to sulfur (Scheme I) 
Figure 2. CID spectrum of I, the monoglutathicme conjugate of 
cyclophosphamide, [Ml-l]+ = 532 Da. 
.Z 
Figure 4. CID spectrum of V, isomeric monoglutathione conju- 
gates of stylene oxide, [MH]+ = 428 Da. 
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WZ 
Figure 5. CID spectrum of XIV, the diglutathione conjugate of 
phenylglyoxal dithiohemiacetal, [ MH]+ = 763 Da. 
appear fairly consistently with m/z 307 (hydrogen 
transfer); however, the complementary R ions are seen 
to be formed by loss of either 307 or 306. Cleavage of 
the C-S bond within the glutathione moiety also pro- 
duces complementary ions, labeled d and k in Scheme 
I. The k ions are observed in most cases at m/z 275, 
and their formation is accompanied by hydrogen trans 
fer. However, the complementary d ions listed in Table 
1 are formed by either loss of 274 Da (no hydrogen 
transfer) or 275 Da (hydrogen transfer), varying from 
one conjugate to another. 
The ions formed from compound VIII, the monoglu- 
tathione conjugate of epoxy-dimethylbilirubin, include 
only two of good intensity from the class-characteristic 
suite (Table 1). Its CID spectrum is dominated by 
peaks reflecting cleavage at the methylene bridge of 
bilirubin, namely m/z 300, 313, 329, 636 118, 191. 
Fragmentation characteristic of glutathione occurs on 
either side of the sulfur atom; however, charge is 
retained predominately on the bilirubin moiety in frag- 
ments R and d, reflecting the strong proton affinity of 
the conjugated tetrapyrrole. 
In addition to extensive precedent in the literature, 
the interpretation of these spectra has been further 
supported by examination of the collisionally activated 
decomposition of a number of analogs. These included 
analogs of VIII in which the epoxide was labeled with 
“0 1191 or glutamate had been enzymatically removed 
from glutathione [ 181, analogs of I and XI in which the 
mustard moiety carried four 2H labels [17], and analogs 
of VII in which the glycine carboxy group had been 
converted to methyl and ethyl esters 1241. 
Discussion 
The entries in Table 2 marked D VIII through D XII are 
taken from ref 16, and summarize fragment ions from 
the high-energy CID spectra of the glutathione conju- 
gates indicated in the footnote. Entries V in Table 1 
and DX in Table 2 are both from glutathione conju- 
gates of styrene oxide with unspecified isomeric com- 
position. There are some general differences between 
the data in the two tables, notably the presence of 
more intense [MH - H20]+ peaks in the earlier work 
and of more abundant low-mass ions in the present 
work. The latter is likely the result of the use of a 
floated collision cell, shown to increase transmission of 
ions with proportionally low kinetic energy [29]. These 
spectral and instrumental differences would appear to 
enhance the significance of the common features, most 
notably the perseverance of glutathionyl ions of m/z 
306-308. 
Examination of the combined measurements from 
Tables 1 and 2 indicates that the glutathione moiety 
itself can usually be recognized in product ion scans of 
cations produced by high-energy collisions. These ions, 
m/z 306,307, or 308, are not usually present in spectra 
produced by low-energy collisions [6-111. It will also 
be productive to look for ions formed by the loss of 
306 or 307 Da, especially when the conjugate partner is 
strongly basic. The pair of ions formed by cleavage of 
the C-S bond within glutathione, ions k and d In the 
Gaskell convention [8], can be expected to provide 
additional indications that glutathione is present. Sul- 
fur bonds in thioether cations are also broken readily 
in high-energy CID analysis of cysteine, mercapturate, 
and cysteinylglycine conjugates [ 16,18,30], and can be 
expected to characterize other metabolites derived from 
glutathione conjugates. 
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